Vascular Intervention // Peripheral
Self-Expanding Stent System/0.018”/OTW
Astron® Pulsar ®
155 μm thin struts
4F low profile
Simple stent deployment
155 μm thin struts - thinner than the leading brands1
Thinner struts for low Chronic Outward Force (COF)2
Thinner struts and lower COF make a difference:*
- Lower risk of restenosis3
- Reduced vessel injury and inflammation4
- Faster endothelialization5
*As demonstrated in pre-clinical studies
1mm stent oversizing at 90 days 6
4F Low Profile - Improved acute outcomes vs. 6F7
Potential for safer, faster and simpler procedures than 6F
- Clinically proven lower access site complication rates7
- Shorter compression time8
- 45% smaller puncture site area than 6F9
- No need for a closure device
Simple stent deployment7
Astron® Pulsar ®Indicated for use in patients with atherosclerotic disease of the femoral and infrapopliteal arteries and for the treatment of insufficient results after percutaneous transluminal angioplasty (PTA).*
Technical Data
| Astron Pulsar Stent | |
|---|---|
| Catheter type |
OTW |
| Recommended guide wire |
0.018" |
| Stent material |
Nitinol |
| Strut thickness |
155 μm |
| Stent coating |
proBIO (Amorphous Silicon Carbide) |
| Stent markers |
6 gold markers on each end |
| Sizes |
ø 4 - 7 mm; L: 20 - 80 mm |
| Proximal shaft |
3.6 F, hydrophobic coating |
| Usable length |
70 cm (ø 5.0 - 7.0 mm) 72 cm (ø 4.0 mm, L: 60 - 80 mm) 75 cm (ø 4.0 mm, L: 20 - 40 mm) 120 cm (ø 5.0 - 7.0 mm) 130 cm (ø 4.0 mm, L: 60 - 80 mm) 135 cm (ø 4.0 mm, L: 20 - 40 mm) |
Ordering Information
| 4.0 (4F) | 358939 | 358940 | 358941 | 359347 | 359680 | |||||||||
| 5.0 (4F) | 349267 | 349268 | 349269 | 349270 | 358942 | |||||||||
| 6.0 (4F) | 349275 | 349276 | 349277 | 349278 | 358943 | |||||||||
| 7.0 (4F) | - | 349283 | 349284 | 349285 | 349286 | |||||||||
| 4.0 (4F) | 358944 | 358945 | 358946 | 359346 | 359681 | |||||||||
| 5.0 (4F) | 349271 | 349272 | 349273 | 349274 | 358947 | |||||||||
| 6.0 (4F) | 349279 | 349280 | 349281 | 349282 | 358948 | |||||||||
| 7.0 (4F) | - | 349287 | 349288 | 349289 | 349290 | |||||||||
Contact
1 6.0 mm diameters; BIOTRONIK data on file;
2 6.0 mm diameters. Supera stent not possible to test due to its design and applied test method. BIOTRONIK data on file;
3 As demonstrated in pre-clinical studies: Zhao HQ, Nikanorov A, Virmani R, Jones R, Schwartz LB. Late stent expansion and neointimal proliferation of oversized nitinol stents in peripheral arteries. Cardiovasc. Intervent. Radiol. 2009 Jul; 32(4); 720-6;
4 As demonstrated in pre-clinical studies: Zhao HQ, Nikanorov A, Virmani R, Jones R, Schwartz LB. Late stent expansion and neointimal proliferation of oversized nitinol stents in peripheral arteries. Cardiovasc. Intervent. Radiol. 2009 Jul; 32(4); 720-6;
5 As demonstrated in pre-clinical studies: Konstantinos C. Role of endothelial shear stress in stent restenosis and thrombosis. JACC 2012.; Koppara et al. Circ Cardiovasc Interv 2015; 8: e002427.; EuroIntervention. BIOTRONIK data on file. 2010 Nov;6(5):630-7; Soucy N, Feygin J et al.;
6 Funovic M. Presented at LINC 2017;
7 Bosiers M, et al. 4-French-compatible endovascular material is safe & effective in the treatment of femoropopliteal occlusive disease: Results of the 4EVER Trial. J ENDOVASC THER. 2013; 20: 746-756;
8 Bosiers M, et al. 4-French-compatible endovascular material is safe & effective in the treatment of femoropopliteal occlusive disease: Results of the 4EVER Trial. J ENDOVASC THER. 2013; 20: 746-756;
9 BIOTRONIK data on file.
Leading competitors have been selected based on the PV Stent Revenue Market Shares EU, 2017 and PV Revenue Market Shares APAC 2015; (Source: Milennium Research Group Inc.). Latest SFA self expanding stents for each manufacturer; Supera is a registered trademark of the Abbott Group of Companies; Lifestent is a registered trademark of C.R. Bard; Zilver is a registered trademark of Cook Medical; EverFlex and Entrust are registered trademarks of the Medtronic Group of Companies; Innova is a registered trademark of Boston Scientific.
*Indication as per IFU.